JHOP March 2013

Page 1

March 2013 Vol 3 I No 1

Journal OF

hematology Oncology ™ Pharmacy The Peer-Reviewed Forum for Oncology Pharmacy Practice

TM

ORIGINAL RESEARCH

Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer Robert Mancini, PharmD, BCOP; Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN Review article

Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma Michael K. Wong, MD, PhD, FRCPC; Anthony Jarkowski III, PharmD, BCOP

From the Literature Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy By Robert J. Ignoffo, PharmD, FASHP, FCSHP, Section Editor

WWW.JHOPONLINE.COM

©2013 Green Hill Healthcare Communications, LLC


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.